Literature DB >> 158743

[Vasogenic cerebral oedema. Changes in membrane ATPases. Correction by a phospholipid precursor (author's transl)].

F Cohadon, M Rigoulet, B Guérin, M Vandendriessche.   

Abstract

In vasogenic cerebral oedema, there is progressive quantitative and qualitative impairment of mitochondrial ATPase and of Na/K/ATPase. This impairment, which reflects the intracellular component of cerebral oedema, would appear to be related to changes in the phospholipid environment of the cell membrane enzymes. CDP choline, a metabolic phospholipid precursor, is to a certain extent capable of correcting this disturbed activity and at the same time reduce oedema.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 158743

Source DB:  PubMed          Journal:  Nouv Presse Med        ISSN: 0301-1518


  4 in total

1.  Neuroprotective effects of Bacopa monnieri in experimental model of dementia.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Neurochem Res       Date:  2012-06-15       Impact factor: 3.996

2.  Effect of oral CDP-choline on visual function in young amblyopic patients.

Authors:  Michela Fresina; Anna Dickmann; Annabella Salerni; Fabio De Gregorio; Emilio C Campos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-07-19       Impact factor: 3.117

Review 3.  Role of Citicoline in the Management of Traumatic Brain Injury.

Authors:  Julio J Secades
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-26

4.  Pomegranate from Oman Alleviates the Brain Oxidative Damage in Transgenic Mouse Model of Alzheimer's disease.

Authors:  Selvaraju Subash; Musthafa Mohamed Essa; Abdullah Al-Asmi; Samir Al-Adawi; Ragini Vaishnav; Nady Braidy; Thamilarasan Manivasagam; Gilles J Guillemin
Journal:  J Tradit Complement Med       Date:  2014-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.